Valuation: Laurus Labs Limited

Capitalization 543B 5.93B 5.05B 4.69B 4.39B 8.18B 8.67B 53.5B 21.2B 256B 22.23B 21.78B 939B P/E ratio 2026 *
74.5x
P/E ratio 2027 * 56.8x
Enterprise value 569B 6.21B 5.28B 4.91B 4.6B 8.57B 9.08B 56.02B 22.2B 269B 23.28B 22.8B 983B EV / Sales 2026 *
8.54x
EV / Sales 2027 * 7.43x
Free-Float
66.1%
Yield 2026 *
0.16%
Yield 2027 * 0.17%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.44%
1 week-6.18%
Current month-8.83%
1 month-5.45%
3 months+8.11%
6 months+22.82%
Current year-8.83%
More quotes
1 week 980.1
Extreme 980.1
1,075.8
1 month 980.1
Extreme 980.1
1,141
Current year 980.1
Extreme 980.1
1,141
1 year 501.15
Extreme 501.15
1,141
3 years 278.85
Extreme 278.85
1,141
5 years 278.85
Extreme 278.85
1,141
10 years 59
Extreme 59
1,141
More quotes
Manager TitleAgeSince
Chief Executive Officer 65 2006-01-20
Director of Finance/CFO - 2006-11-29
Chief Operating Officer - 2008-04-01
Director TitleAgeSince
Director/Board Member 65 2006-01-20
Director/Board Member 68 2016-07-06
Director/Board Member - 2016-07-26
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.77%-6.18%+72.64%+189.54% 5.93B
+0.82%+5.27%+44.22%+214.21% 974B
+0.22%-0.49%+50.40%+29.48% 526B
+0.91%+0.63%+28.91%+45.81% 385B
+0.20%+0.11%+27.30%+18.23% 376B
+0.34%-3.06%+23.32%+23.41% 284B
+0.38%+0.22%+28.36%+35.62% 279B
-1.74%-1.61%+14.11%-0.69% 271B
+2.22%+4.71%-29.91%-15.65% 277B
+1.01%+5.16%+26.93%+31.85% 187B
Average +0.49%+0.77%+28.63%+57.18% 356.55B
Weighted average by Cap. +0.53%+2.09%+29.88%+75.09%
See all sector performances

Financials

2026 *2027 *
Net sales 66.59B 727M 619M 575M 539M 1B 1.06B 6.56B 2.6B 31.45B 2.73B 2.67B 115B 76.65B 837M 712M 661M 620M 1.15B 1.22B 7.55B 2.99B 36.21B 3.14B 3.07B 132B
Net income 7.22B 78.83M 67.09M 62.31M 58.42M 109M 115M 711M 282M 3.41B 296M 290M 12.48B 9.54B 104M 88.66M 82.34M 77.2M 144M 152M 940M 373M 4.51B 391M 383M 16.49B
Net Debt 25.62B 280M 238M 221M 207M 386M 409M 2.52B 1B 12.1B 1.05B 1.03B 44.28B 26.28B 287M 244M 227M 213M 396M 420M 2.59B 1.03B 12.42B 1.08B 1.05B 45.44B
More financial data * Estimated data
Logo Laurus Labs Limited
Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. The Company offers integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. It operates through four divisions: Generics API, Generics FDF, Laurus Synthesis, and Laurus Bio. The Generics API is a third-party API supplier for antiretrovirals. The Generic FDF business focuses on oral solid formulations. The Laurus Synthesis provides drug development and manufacturing services to global pharma, crop science, animal health, and others. The Laurus Bio offers comprehensive services from clone and strain engineering to production, supporting clients across the microbial precision fermentation spectrum. The Company operates through two geographical segments: Revenue from customers within India-Domestic, and Revenue from customers outside India-Exports.
Employees
6,167
More about the company
Date Price Change Volume
26-01-23 1,013.40 +0.76% 3,824,275
26-01-22 1,005.80 +1.81% 4,268,831
26-01-21 987.90 -4.60% 2,490,377
26-01-20 1,035.50 -2.56% 2,915,781
26-01-19 1,062.70 -1.31% 4,147,522

Delayed Quote NSE India S.E., January 23, 2026 at 04:46 am EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
1,005.80INR
Average target price
863.13INR
Spread / Average Target
-14.18%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. LAURUSLABS Stock